Evidence map›Paper›PMID 41181452›Full record

ArticleAnnals of medicine and surgery (2012)2025

Unmasking TRALI: a case report of multiple myeloma and transfusion-associated event.

Morteza Sanei Taheri, Mehdi Yousefipour, Amirreza Heidarian

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Morteza Sanei TaheriDepartment of Radiology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-8881-9058
Mehdi YousefipourDepartment of Infectious diseases, Madaen hospital, Tehran, Iran.ORCID https://orcid.org/0000-0002-7479-3336
Amirreza HeidarianDepartment of Radiology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Transfusion-related acute lung injury (TRALI) is a relatively rare but severe respiratory complication that can occur following the transfusion of blood products. Despite its infrequent occurrence, TRALI is a leading cause of transfusion-related mortality, underscoring the need for rapid diagnosis and appropriate management. However, diagnosis remains challenging due to its clinical overlap with other causes of acute respiratory distress syndrome (ARDS). Case presentation: This report describes the case of a 57-year-old woman with multiple myeloma (MM) who developed acute respiratory distress consistent with TRALI 4 hours after receiving a whole blood transfusion for severe pancytopenia. Clinical discussion: This case highlights the diagnostic difficulties in distinguishing TRALI from other post-transfusion complications, including transfusion-associated circulatory overload (TACO), allergic reactions, cardiac complications, and infectious processes. It also emphasizes the need for a high index of suspicion in susceptible patients. We discuss the potential risk factors, underlying pathophysiology, and essential elements of the differential diagnosis. Conclusion: Increased awareness and early recognition of TRALI are essential for improving patient outcomes. Moreover, this case aligns with the existing literature by highlighting the diagnostic challenges and the importance of considering TRALI in patients with hematological malignancies who require transfusion support.

Indexed as

blood transfusioncase reportmultiple myelomaTRALItransfusion-related acute lung injury

Identifiers

PMID41181452
PMCPMC12578070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.